person · Reporting owner
Dixon Heather Brianne
Disclosed activity across 5 companies
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Acadia Healthcare Company, Inc.ACHC · Entity 4312 | Chief Financial Officer | July 25, 2025 | July 29, 2025 |
| Addus HomeCare CorpADUS · Entity 4454 | President and Chief Operating | June 22, 2026 | June 23, 2026 |
| Walgreens Boots Alliance, Inc.WBA · Entity 16467 | SVP, Global Controller and CAO | May 01, 2021 | May 04, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Acadia Healthcare Company, Inc.
Report date July 25, 2025 · Filed July 29, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 118,581 |
Reported balance
After 2025-07-25 transaction · row 1
1 source rowRow 1 · 2025-07-25 · Tax withholding · Disposed 2,410 · Balance 118,581 |
Addus HomeCare Corp
Report date June 22, 2026 · Filed June 23, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 44,371 |
Reported balance
After 2026-06-22 transaction · row 1
1 source rowRow 1 · 2026-06-22 · Sale · Disposed 288 · Balance 44,371 F1: This transaction reflects the sale of shares, made pursuant to a previously established 10b5-1 plan, for the purpose of satisfying tax obligations due upon the vesting of restricted stock awards granted by the Issuer. F2: Adoption date of referenced 10b5-1(c) plan is: 11-06-2025 |
Filing footnotes · ownership attribution and instrument terms
F1: This transaction reflects the sale of shares, made pursuant to a previously established 10b5-1 plan, for the purpose of satisfying tax obligations due upon the vesting of restricted stock awards granted by the Issuer.
F2: Adoption date of referenced 10b5-1(c) plan is: 11-06-2025
Walgreens Boots Alliance, Inc.
Report date May 01, 2021 · Filed May 04, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 18,887 |
Reported balance
After 2021-05-01 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2021-05-01 · Grant · Acquired 7,533 · Balance 18,887 F1: Restricted stock unit award granted under the Walgreens Boots Alliance, Inc. 2021 Omnibus Incentive Plan (together with the related award agreement and the applicable election forms thereunder, the "Plan") vests on the first anniversary of the May 1, 2021 date of grant, subject to acceleration or forfeiture in certain circumstances in accordance with the terms and conditions of the Plan. F2: Includes shares underlying restricted stock units issued in lieu of dividends (through May 1, 2021) on outstanding restricted stock units. |
Filing footnotes · ownership attribution and instrument terms
F1: Restricted stock unit award granted under the Walgreens Boots Alliance, Inc. 2021 Omnibus Incentive Plan (together with the related award agreement and the applicable election forms thereunder, the "Plan") vests on the first anniversary of the May 1, 2021 date of grant, subject to acceleration or forfeiture in certain circumstances in accordance with the terms and conditions of the Plan.
F2: Includes shares underlying restricted stock units issued in lieu of dividends (through May 1, 2021) on outstanding restricted stock units.
Past disclosures · reporting ended (2)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
AETNA INC /PA/
Report date November 28, 2018 · Filed November 28, 2018
Section 16 reporting ended · disclosed 2018-11-28. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Appreciation RightsSEC Table II · derivative / convertible security · Conversion / exercise price $116.22 | Direct | 0 |
Reported balance
After 2018-11-28 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2018-11-28 · Disposition to issuer · Disposed 2,706 · Balance 0 F1: Represents Stock Appreciation Rights ("SARs") granted under the Aetna Inc. 2010 Stock Incentive Plan (the "Plan") on September 12, 2016, of which 66.7% had vested. Each vested SAR was canceled pursuant to the terms of the merger agreement (the "Merger Agreement") between CVS Health Corporation ("CVS Health") and Aetna Inc. ("Aetna") in exchange for an amount in cash for each SAR equal to (a) $145 plus (b) 0.8378 multiplied by the average of the volume weighted averages of the trading prices of CVS Health Common Stock on each of the five consecutive trading days ending on the trading day two trading days prior to the closing date, less (c) the exercise price (the "SAR Amount"). Each unvested SAR was converted to a CVS Health SAR pursuant to the terms of the Merger Agreement. |
| Stock Appreciation RightsSEC Table II · derivative / convertible security · Conversion / exercise price $125.27 | Direct | 0 |
Reported balance
After 2018-11-28 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2018-11-28 · Disposition to issuer · Disposed 2,890 · Balance 0 F2: Represents SARs granted under the Plan on February 17, 2017, of which 33.3% had vested. Each vested SAR was canceled pursuant to the terms of the Merger Agreement in exchange for an amount in cash equal to the SAR Amount. Each unvested SAR was converted to a CVS Health SAR pursuant to the terms of the Merger Agreement. |
| Performance Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2018-11-28 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2018-11-28 · Disposition to issuer · Disposed 776 · Balance 0 F3: Represents Performance Stock Units ("PSUs") earned at a specified level in conjunction with the change in control of Aetna and pursuant to the terms of the relevant PSU award agreement. The PSUs were originally granted under the Plan on September 12, 2016. These PSUs were converted to time-vesting CVS Health Restricted Stock Units ("RSUs") pursuant to the terms of the Merger Agreement. |
| Performance Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2018-11-28 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2018-11-28 · Disposition to issuer · Disposed 360 · Balance 0 F4: PSUs earned at a specified level in conjunction with the change in control of Aetna and pursuant to the terms of the relevant PSU award agreement. The PSUs were originally granted under the Plan on February 17, 2017. These PSUs were converted to time-vesting CVS Health RSUs pursuant to the terms of the Merger Agreement. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2018-11-28 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2018-11-28 · Disposition to issuer · Disposed 1,606 · Balance 0 F5: RSUs granted under the Plan on March 2, 2018. These RSUs were converted to CVS Health RSUs pursuant to the terms of the Merger Agreement. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents Stock Appreciation Rights ("SARs") granted under the Aetna Inc. 2010 Stock Incentive Plan (the "Plan") on September 12, 2016, of which 66.7% had vested. Each vested SAR was canceled pursuant to the terms of the merger agreement (the "Merger Agreement") between CVS Health Corporation ("CVS Health") and Aetna Inc. ("Aetna") in exchange for an amount in cash for each SAR equal to (a) $145 plus (b) 0.8378 multiplied by the average of the volume weighted averages of the trading prices of CVS Health Common Stock on each of the five consecutive trading days ending on the trading day two trading days prior to the closing date, less (c) the exercise price (the "SAR Amount"). Each unvested SAR was converted to a CVS Health SAR pursuant to the terms of the Merger Agreement.
F2: Represents SARs granted under the Plan on February 17, 2017, of which 33.3% had vested. Each vested SAR was canceled pursuant to the terms of the Merger Agreement in exchange for an amount in cash equal to the SAR Amount. Each unvested SAR was converted to a CVS Health SAR pursuant to the terms of the Merger Agreement.
F3: Represents Performance Stock Units ("PSUs") earned at a specified level in conjunction with the change in control of Aetna and pursuant to the terms of the relevant PSU award agreement. The PSUs were originally granted under the Plan on September 12, 2016. These PSUs were converted to time-vesting CVS Health Restricted Stock Units ("RSUs") pursuant to the terms of the Merger Agreement.
F4: PSUs earned at a specified level in conjunction with the change in control of Aetna and pursuant to the terms of the relevant PSU award agreement. The PSUs were originally granted under the Plan on February 17, 2017. These PSUs were converted to time-vesting CVS Health RSUs pursuant to the terms of the Merger Agreement.
F5: RSUs granted under the Plan on March 2, 2018. These RSUs were converted to CVS Health RSUs pursuant to the terms of the Merger Agreement.
Signify Health, Inc.
Report date March 29, 2023 · Filed March 29, 2023
Section 16 reporting ended · disclosed 2023-03-29. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 0 |
Ending reported balance
After 2023-03-29 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2023-03-29 · Disposition to issuer · Disposed 14,672 · Balance 15,002 F1: On March 29, 2023, pursuant to that certain Agreement and Plan of Merger, dated September 2, 2022, between the Issuer, CVS Pharmacy, Inc. ("Parent") and Noah Merger Sub, Inc. (the "Merger Agreement"), each restricted stock unit with respect to shares of the Issuer's Class A Common Stock (each, an "Issuer RSU"), that was (i) outstanding immediately prior to the effective time of the merger (the "Effective Time") to the extent vested and unsettled and (ii) any Issuer RSU that was outstanding immediately prior to the Effective Time and was held by any person who is a non-employee director, consultant or independent contractor engaged by the Issuer (each, a "Cash-Out RSU"), was cancelled and converted into the right to receive an amount in cash equal to (1) to $30.50 (the "Per Share Consideration") multiplied by (2) the number of shares of the Issuer's Class A Common Stock subject to such Cash-Out RSU. Row 2 · 2023-03-29 · Disposition to issuer · Disposed 15,002 · Balance 0 F2: Pursuant to the Merger Agreement, each share of Class A Common Stock outstanding and held by the Reporting Person immediately prior to the Effective Time, was cancelled and converted into the right to receive the Per Share Consideration. |
Filing footnotes · ownership attribution and instrument terms
F1: On March 29, 2023, pursuant to that certain Agreement and Plan of Merger, dated September 2, 2022, between the Issuer, CVS Pharmacy, Inc. ("Parent") and Noah Merger Sub, Inc. (the "Merger Agreement"), each restricted stock unit with respect to shares of the Issuer's Class A Common Stock (each, an "Issuer RSU"), that was (i) outstanding immediately prior to the effective time of the merger (the "Effective Time") to the extent vested and unsettled and (ii) any Issuer RSU that was outstanding immediately prior to the Effective Time and was held by any person who is a non-employee director, consultant or independent contractor engaged by the Issuer (each, a "Cash-Out RSU"), was cancelled and converted into the right to receive an amount in cash equal to (1) to $30.50 (the "Per Share Consideration") multiplied by (2) the number of shares of the Issuer's Class A Common Stock subject to such Cash-Out RSU.
F2: Pursuant to the Merger Agreement, each share of Class A Common Stock outstanding and held by the Reporting Person immediately prior to the Effective Time, was cancelled and converted into the right to receive the Per Share Consideration.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 22, 2026 Filed Jun 23, 2026 20:30 UTC | Addus HomeCare Corp ADUS · Entity 4454 | SaleCommon Stock | 288 | $93.77 | $27,005.76 |
DisclosureSEC source: 0001437749-26-021450 · rdgdoc.xml · nonDerivative · entry 1 Dixon Heather Brianne · CIK 0001720793 · President and Chief Operating 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 44,371 F1 · kind: This transaction reflects the sale of shares, made pursuant to a previously established 10b5-1 plan, for the purpose of satisfying tax obligations due upon the vesting of restricted stock awards granted by the Issuer. F2 · kind: Adoption date of referenced 10b5-1(c) plan is: 11-06-2025 Read SEC document |
| February 20, 2026 Filed Feb 24, 2026 21:00 UTC | Addus HomeCare Corp ADUS · Entity 4454 | GrantCommon Stock | 12,470 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-26-005318 · rdgdoc.xml · nonDerivative · entry 1 Dixon Heather Brianne · CIK 0001720793 · President and Chief Operating 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,659 F1 · shares: The shares vest in equal installments on each of February 20, 2027, February 20, 2028, and February 20, 2029, subject to customary provisions for continued service and acceleration on a change in control. Read SEC document |
| September 15, 2025 Filed Sep 16, 2025 20:35 UTC | Addus HomeCare Corp ADUS · Entity 4454 | GrantCommon Stock | 28,370 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-029176 · rdgdoc.xml · nonDerivative · entry 1 Dixon Heather Brianne · CIK 0001720793 · President and Chief Operating 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,189 F1 · shares: The shares vest in equal installments on each of September 15, 2026, September 15, 2027, and September 15, 2028, subject to customary provisions for continued service and acceleration on a change in control. Read SEC document |
| July 25, 2025 Filed Jul 29, 2025 21:01 UTC | Acadia Healthcare Company, Inc. ACHC · Entity 4312 | Tax withholdingCommon Stock | 2,410 | $21.74 | $52,393.40 |
DisclosureSEC source: 0000950170-25-099722 · ownership.xml · nonDerivative · entry 1 Dixon Heather Brianne · CIK 0001720793 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 118,581 Read SEC document |
| June 26, 2025 Filed Jun 27, 2025 21:01 UTC | Acadia Healthcare Company, Inc. ACHC · Entity 4312 | Tax withholdingCommon Stock | 1,508 | $20.94 | $31,577.52 |
DisclosureSEC source: 0000950170-25-091001 · ownership.xml · nonDerivative · entry 1 Dixon Heather Brianne · CIK 0001720793 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 120,991 Read SEC document |
| June 18, 2025 Filed Jun 20, 2025 20:30 UTC | Addus HomeCare Corp ADUS · Entity 4454 | GrantCommon Stock | 1,172 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-088533 · ownership.xml · nonDerivative · entry 1 Dixon Heather Brianne · CIK 0001720793 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,819 F1 · shares: Restricted shares granted to non-employee directors that will vest in full on June 18, 2026. Read SEC document |
| May 05, 2025 Filed May 7, 2025 22:02 UTC | Acadia Healthcare Company, Inc. ACHC · Entity 4312 | GrantCommon Stock | 43,823 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-066062 · ownership.xml · nonDerivative · entry 1 Dixon Heather Brianne · CIK 0001720793 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 122,499 F1 · shares: Shares will vest over a 3-year period in equal yearly installments beginning May 5, 2026. Read SEC document |
| February 27, 2025 Filed Feb 28, 2025 22:58 UTC | Acadia Healthcare Company, Inc. ACHC · Entity 4312 | GrantCommon Stock | 11,659 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-030198 · ownership.xml · nonDerivative · entry 1 Dixon Heather Brianne · CIK 0001720793 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 78,676 F1 · shares: Shares earned based on 2024 performance under performance vesting restricted stock units awarded on July 25, 2023. The shares will not be issued until the end of the three-year period under the restricted stock unit award. Read SEC document |
| July 25, 2024 Filed Jul 29, 2024 21:01 UTC | Acadia Healthcare Company, Inc. ACHC · Entity 4312 | Tax withholdingCommon Stock | 2,902 | $66.28 | $192,344.56 |
DisclosureSEC source: 0000950170-24-087347 · ownership.xml · nonDerivative · entry 1 Dixon Heather Brianne · CIK 0001720793 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 67,017 Read SEC document |
| June 26, 2024 Filed Jun 28, 2024 21:01 UTC | Acadia Healthcare Company, Inc. ACHC · Entity 4312 | GrantCommon Stock | 15,447 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-079132 · ownership.xml · nonDerivative · entry 1 Dixon Heather Brianne · CIK 0001720793 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 69,919 F1 · shares: Shares will vest over a 3-year period in equal yearly installments beginning June 26, 2025. Read SEC document |
| June 12, 2024 Filed Jun 13, 2024 20:05 UTC | Addus HomeCare Corp ADUS · Entity 4454 | GrantCommon Stock | 1,013 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-072980 · ownership.xml · nonDerivative · entry 1 Dixon Heather Brianne · CIK 0001720793 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,647 F1 · shares: Restricted shares granted to non-employee directors that will vest in full on June 12, 2025. Read SEC document |
| February 28, 2024 Filed Mar 1, 2024 23:22 UTC | Acadia Healthcare Company, Inc. ACHC · Entity 4312 | GrantCommon Stock | 21,560 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-024132 · ownership.xml · nonDerivative · entry 1 Dixon Heather Brianne · CIK 0001720793 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54,472 F1 · shares: Shares earned based on 2023 performance under performance vesting restricted stock units awarded on July 25, 2023. The shares will not be issued until the end of the three-year period under the restricted stock unit award. Read SEC document |
| July 25, 2023 Filed Jul 27, 2023 21:12 UTC | Acadia Healthcare Company, Inc. ACHC · Entity 4312 | GrantCommon Stock | 32,912 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-23-035225 · ownership.xml · nonDerivative · entry 1 Dixon Heather Brianne · CIK 0001720793 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,912 F1 · shares: Shares will vest over a 4-year period in equal yearly installments beginning July 25, 2024. Read SEC document |
| June 14, 2023 Filed Jun 16, 2023 20:57 UTC | Addus HomeCare Corp ADUS · Entity 4454 | GrantCommon Stock | 1,289 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-037945 · doc4.xml · nonDerivative · entry 1 Dixon Heather Brianne · CIK 0001720793 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,634 F1 · shares: Restricted shares granted to non-employee directors that will vest in full on June 14, 2024. Read SEC document |
| March 29, 2023 Filed Mar 29, 2023 12:58 UTC | Signify Health, Inc. SGFY · Entity 114996 | Disposition to issuerClass A Common Stock | 15,002 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-23-009942 · doc4.xml · nonDerivative · entry 2 Dixon Heather Brianne · CIK 0001720793 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F2 · kind: Pursuant to the Merger Agreement, each share of Class A Common Stock outstanding and held by the Reporting Person immediately prior to the Effective Time, was cancelled and converted into the right to receive the Per Share Consideration. F2 · price: Pursuant to the Merger Agreement, each share of Class A Common Stock outstanding and held by the Reporting Person immediately prior to the Effective Time, was cancelled and converted into the right to receive the Per Share Consideration. Read SEC document |
| March 29, 2023 Filed Mar 29, 2023 12:58 UTC | Signify Health, Inc. SGFY · Entity 114996 | Disposition to issuerClass A Common Stock | 14,672 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-23-009942 · doc4.xml · nonDerivative · entry 1 Dixon Heather Brianne · CIK 0001720793 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,002 F1 · kind: On March 29, 2023, pursuant to that certain Agreement and Plan of Merger, dated September 2, 2022, between the Issuer, CVS Pharmacy, Inc. ("Parent") and Noah Merger Sub, Inc. (the "Merger Agreement"), each restricted stock unit with respect to shares of the Issuer's Class A Common Stock (each, an "Issuer RSU"), that was (i) outstanding immediately prior to the effective time of the merger (the "Effective Time") to the extent vested and unsettled and (ii) any Issuer RSU that was outstanding immediately prior to the Effective Time and was held by any person who is a non-employee director, consultant or independent contractor engaged by the Issuer (each, a "Cash-Out RSU"), was cancelled and converted into the right to receive an amount in cash equal to (1) to $30.50 (the "Per Share Consideration") multiplied by (2) the number of shares of the Issuer's Class A Common Stock subject to such Cash-Out RSU. F1 · price: On March 29, 2023, pursuant to that certain Agreement and Plan of Merger, dated September 2, 2022, between the Issuer, CVS Pharmacy, Inc. ("Parent") and Noah Merger Sub, Inc. (the "Merger Agreement"), each restricted stock unit with respect to shares of the Issuer's Class A Common Stock (each, an "Issuer RSU"), that was (i) outstanding immediately prior to the effective time of the merger (the "Effective Time") to the extent vested and unsettled and (ii) any Issuer RSU that was outstanding immediately prior to the Effective Time and was held by any person who is a non-employee director, consultant or independent contractor engaged by the Issuer (each, a "Cash-Out RSU"), was cancelled and converted into the right to receive an amount in cash equal to (1) to $30.50 (the "Per Share Consideration") multiplied by (2) the number of shares of the Issuer's Class A Common Stock subject to such Cash-Out RSU. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 21:22 UTC | Addus HomeCare Corp ADUS · Entity 4454 | GrantCommon Stock | 345 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-015485 · doc4.xml · nonDerivative · entry 1 Dixon Heather Brianne · CIK 0001720793 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 345 F1 · shares: Restricted shares granted to non-employee directors that will vest in full on June 15, 2023. Read SEC document |
| May 19, 2022 Filed May 23, 2022 23:35 UTC | Signify Health, Inc. SGFY · Entity 114996 | GrantClass A Common Stock | 14,672 | $0.00 | $0.00 |
DisclosureSEC source: 0000950103-22-009037 · dp173666_4-dixon.xml · nonDerivative · entry 1 Dixon Heather Brianne · CIK 0001720793 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,674 F1 · shares: Represents a grant of restricted stock units on May 19, 2022 that will vest on the first anniversary of the grant date. Read SEC document |
| May 13, 2021 Filed May 17, 2021 21:05 UTC | Signify Health, Inc. SGFY · Entity 114996 | GrantClass A Common Stock | 15,002 | $0.00 | $0.00 |
DisclosureSEC source: 0000950103-21-007354 · dp151187_4-dixon.xml · nonDerivative · entry 1 Dixon Heather Brianne · CIK 0001720793 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,002 F1 · shares: Represents two grants of restricted stock units on May 13, 2021, each with respect to 7,501 shares of our Class A common stock, that will each vest on the first anniversary of the grant date. Read SEC document |
| May 01, 2021 Filed May 4, 2021 18:53 UTC | Walgreens Boots Alliance, Inc. WBA · Entity 16467 | GrantCommon Stock | 7,533 | $0.00 | $0.00 |
DisclosureSEC source: 0001618921-21-000047 · wf-form4_162016880575451.xml · nonDerivative · entry 1 Dixon Heather Brianne · CIK 0001720793 · SVP, Global Controller and CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,887 F1 · kind: Restricted stock unit award granted under the Walgreens Boots Alliance, Inc. 2021 Omnibus Incentive Plan (together with the related award agreement and the applicable election forms thereunder, the "Plan") vests on the first anniversary of the May 1, 2021 date of grant, subject to acceleration or forfeiture in certain circumstances in accordance with the terms and conditions of the Plan. F2 · balance_after: Includes shares underlying restricted stock units issued in lieu of dividends (through May 1, 2021) on outstanding restricted stock units. Read SEC document |
| November 01, 2020 Filed Nov 2, 2020 16:41 UTC | Walgreens Boots Alliance, Inc. WBA · Entity 16467 | GrantEmployee Stock Option (Right to Buy) · Derivative | 30,941 | $0.00 Strike: $34.04 | $0.00 |
DisclosureSEC source: 0001618921-20-000120 · wf-form4_160435325480865.xml · derivative · entry 3 Dixon Heather Brianne · CIK 0001720793 · SVP, Global Controller and CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,941 Underlying: Common Stock · 30,941 shares Expires 2030-11-01 F4 · derivative.exercise_date: The option vests with respect to 10,303 shares on November 1, 2021, with respect to 10,303 shares on November 1, 2022, and with respect to 10,335 shares on November 1, 2023, subject to acceleration or forfeiture in certain circumstances in accordance with the terms and conditions of the amended and restated Walgreens Boots Alliance, Inc. 2013 Omnibus Incentive Plan (together with the related grant agreement thereunder). Read SEC document |
| November 01, 2020 Filed Nov 2, 2020 16:41 UTC | Walgreens Boots Alliance, Inc. WBA · Entity 16467 | Tax withholdingCommon Stock | 340 | $34.04 | $11,573.60 |
DisclosureSEC source: 0001618921-20-000120 · wf-form4_160435325480865.xml · nonDerivative · entry 2 Dixon Heather Brianne · CIK 0001720793 · SVP, Global Controller and CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,111 F3 · kind: Disposition relating to the satisfaction of tax withholding obligations upon the vesting of restricted stock unit award granted in accordance with Rule 16b-3. F2 · balance_after: Includes shares underlying restricted stock units issued in lieu of dividends (through October 31, 2020) on outstanding restricted stock units. Read SEC document |
| November 01, 2020 Filed Nov 2, 2020 16:41 UTC | Walgreens Boots Alliance, Inc. WBA · Entity 16467 | GrantCommon Stock | 6,173 | $0.00 | $0.00 |
DisclosureSEC source: 0001618921-20-000120 · wf-form4_160435325480865.xml · nonDerivative · entry 1 Dixon Heather Brianne · CIK 0001720793 · SVP, Global Controller and CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,451 F1 · kind: Restricted stock unit award granted under the amended and restated Walgreens Boots Alliance, Inc. 2013 Omnibus Incentive Plan (together with the related award agreement and the applicable election forms thereunder, the "Plan") vests in one-third increments on each of the first, second and third anniversaries of the November 1, 2020 date of grant, subject to acceleration or forfeiture in certain circumstances in accordance with the terms and conditions of the Plan. F2 · balance_after: Includes shares underlying restricted stock units issued in lieu of dividends (through October 31, 2020) on outstanding restricted stock units. Read SEC document |
| September 01, 2020 Filed Sep 2, 2020 18:58 UTC | Walgreens Boots Alliance, Inc. WBA · Entity 16467 | Exercise / conversionRestricted Stock Units · Derivative | 2,539 | $0.00 | $0.00 |
DisclosureSEC source: 0001618921-20-000075 · wf-form4_159908748006414.xml · derivative · entry 3 Dixon Heather Brianne · CIK 0001720793 · SVP, Global Controller and CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,539 Underlying: Common Stock · 2,539 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock of Walgreens Boots Alliance, Inc., subject to the terms and conditions of the Plan. F1 · kind: Shares issued upon settlement of restricted stock unit award granted on September 8, 2019 under the amended and restated Walgreens Boots Alliance, Inc. 2013 Omnibus Incentive Plan (together with the related award agreement and the applicable election forms thereunder, the "Plan"). F5 · shares: Includes 97 restricted stock units issued in lieu of dividends (through August 31, 2020) on restricted stock units that vested on September 1, 2020. F6 · derivative.exercise_date: The restricted stock units granted on September 8, 2019 vest in two equal annual installments, beginning on September 1, 2020. Vested shares will be delivered as promptly as practicable following the vesting of the restricted stock units, subject to the terms and conditions of the Plan. F6 · derivative.expiration_date: The restricted stock units granted on September 8, 2019 vest in two equal annual installments, beginning on September 1, 2020. Vested shares will be delivered as promptly as practicable following the vesting of the restricted stock units, subject to the terms and conditions of the Plan. F7 · balance_after: Includes restricted stock units issued in lieu of dividends (through August 31, 2020) on outstanding restricted stock units granted on September 8, 2019. Read SEC document |
| September 01, 2020 Filed Sep 2, 2020 18:58 UTC | Walgreens Boots Alliance, Inc. WBA · Entity 16467 | Tax withholdingCommon Stock | 744 | $36.76 | $27,349.44 |
DisclosureSEC source: 0001618921-20-000075 · wf-form4_159908748006414.xml · nonDerivative · entry 2 Dixon Heather Brianne · CIK 0001720793 · SVP, Global Controller and CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,278 F4 · kind: Disposition relating to the satisfaction of tax withholding obligations upon the vesting of restricted stock unit award granted in accordance with Rule 16b-3. F3 · balance_after: Includes restricted stock units granted on November 1, 2019 and restricted stock units issued in lieu of dividends (through August 31, 2020) on such restricted stock units. Read SEC document |
| September 01, 2020 Filed Sep 2, 2020 18:58 UTC | Walgreens Boots Alliance, Inc. WBA · Entity 16467 | Exercise / conversionCommon Stock | 2,539 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001618921-20-000075 · wf-form4_159908748006414.xml · nonDerivative · entry 1 Dixon Heather Brianne · CIK 0001720793 · SVP, Global Controller and CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,022 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Shares issued upon settlement of restricted stock unit award granted on September 8, 2019 under the amended and restated Walgreens Boots Alliance, Inc. 2013 Omnibus Incentive Plan (together with the related award agreement and the applicable election forms thereunder, the "Plan"). F2 · price: Each restricted stock unit represents a contingent right to receive one share of common stock of Walgreens Boots Alliance, Inc., subject to the terms and conditions of the Plan. F3 · balance_after: Includes restricted stock units granted on November 1, 2019 and restricted stock units issued in lieu of dividends (through August 31, 2020) on such restricted stock units. Read SEC document |
| November 01, 2019 Filed Nov 4, 2019 17:46 UTC | Walgreens Boots Alliance, Inc. WBA · Entity 16467 | GrantEmployee Stock Option (right to buy) · Derivative | 20,220 | $0.00 Strike: $57.38 | $0.00 |
DisclosureSEC source: 0001618921-19-000107 · edgar.xml · derivative · entry 2 Dixon Heather Brianne · CIK 0001720793 · SVP, Global Controller and CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,220 Underlying: Common Stock · 20,220 shares Expires 2029-11-01 F2 · derivative.exercise_date: The option vests with respect to 6,733 shares on November 1, 2020, with respect to 6,733 shares on November 1, 2021, and with respect to 6,754 shares on November 1, 2022, subject to acceleration or forfeiture in certain circumstances in accordance with the terms and conditions of the Plan. Read SEC document |
| November 01, 2019 Filed Nov 4, 2019 17:46 UTC | Walgreens Boots Alliance, Inc. WBA · Entity 16467 | GrantCommon Stock | 3,350 | $0.00 | $0.00 |
DisclosureSEC source: 0001618921-19-000107 · edgar.xml · nonDerivative · entry 1 Dixon Heather Brianne · CIK 0001720793 · SVP, Global Controller and CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,234 F1 · kind: This is a grant of restricted stock units under the amended and restated Walgreens Boots Alliance, Inc. 2013 Omnibus Incentive Plan (together with the related award agreement and the applicable election forms thereunder, the "Plan"). The shares underlying these restricted stock units vest with respect to 1,116 shares on November 1, 2020, with respect to 1,116 shares on November 1, 2021, and with respect to 1,118 shares on November 1, 2022, subject to acceleration or forfeiture in certain circumstances in accordance with the terms and conditions of the Plan. Read SEC document |
| September 08, 2019 Filed Sep 10, 2019 16:34 UTC | Walgreens Boots Alliance, Inc. WBA · Entity 16467 | GrantRestricted Stock Units · Derivative | 4,884 | $0.00 | $0.00 |
DisclosureSEC source: 0001618921-19-000054 · edgar.xml · derivative · entry 1 Dixon Heather Brianne · CIK 0001720793 · SVP, Global Controller and CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,884 Underlying: Common Stock · 4,884 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock of Walgreens Boots Alliance, Inc. F2 · derivative.exercise_date: The restricted stock units vest in two equal annual installments beginning on September 1, 2020. Vested shares will be delivered as promptly as practical following the vesting of the restricted stock units, subject to the terms and conditions of the amended and restated Walgreens Boots Alliance, Inc. 2013 Omnibus Incentive Plan (together with the related award agreement and the applicable election forms thereunder). F2 · derivative.expiration_date: The restricted stock units vest in two equal annual installments beginning on September 1, 2020. Vested shares will be delivered as promptly as practical following the vesting of the restricted stock units, subject to the terms and conditions of the amended and restated Walgreens Boots Alliance, Inc. 2013 Omnibus Incentive Plan (together with the related award agreement and the applicable election forms thereunder). Read SEC document |
| November 28, 2018 Filed Nov 28, 2018 16:18 UTC | AETNA INC /PA/ AET · Entity 107289 | Disposition to issuerRestricted Stock Units · Derivative | 1,606 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001122304-18-000159 · edgar.xml · derivative · entry 5 Dixon Heather Brianne · CIK 0001720793 · VP, Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,606 shares Expires not disclosed F5 · derivative.exercise_price: RSUs granted under the Plan on March 2, 2018. These RSUs were converted to CVS Health RSUs pursuant to the terms of the Merger Agreement. F5 · price: RSUs granted under the Plan on March 2, 2018. These RSUs were converted to CVS Health RSUs pursuant to the terms of the Merger Agreement. F5 · derivative.exercise_date: RSUs granted under the Plan on March 2, 2018. These RSUs were converted to CVS Health RSUs pursuant to the terms of the Merger Agreement. F5 · derivative.expiration_date: RSUs granted under the Plan on March 2, 2018. These RSUs were converted to CVS Health RSUs pursuant to the terms of the Merger Agreement. Read SEC document |
| November 28, 2018 Filed Nov 28, 2018 16:18 UTC | AETNA INC /PA/ AET · Entity 107289 | Disposition to issuerPerformance Stock Units · Derivative | 360 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001122304-18-000159 · edgar.xml · derivative · entry 4 Dixon Heather Brianne · CIK 0001720793 · VP, Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 360 shares Expires not disclosed F4 · derivative.exercise_price: PSUs earned at a specified level in conjunction with the change in control of Aetna and pursuant to the terms of the relevant PSU award agreement. The PSUs were originally granted under the Plan on February 17, 2017. These PSUs were converted to time-vesting CVS Health RSUs pursuant to the terms of the Merger Agreement. F4 · price: PSUs earned at a specified level in conjunction with the change in control of Aetna and pursuant to the terms of the relevant PSU award agreement. The PSUs were originally granted under the Plan on February 17, 2017. These PSUs were converted to time-vesting CVS Health RSUs pursuant to the terms of the Merger Agreement. F4 · derivative.exercise_date: PSUs earned at a specified level in conjunction with the change in control of Aetna and pursuant to the terms of the relevant PSU award agreement. The PSUs were originally granted under the Plan on February 17, 2017. These PSUs were converted to time-vesting CVS Health RSUs pursuant to the terms of the Merger Agreement. F4 · derivative.expiration_date: PSUs earned at a specified level in conjunction with the change in control of Aetna and pursuant to the terms of the relevant PSU award agreement. The PSUs were originally granted under the Plan on February 17, 2017. These PSUs were converted to time-vesting CVS Health RSUs pursuant to the terms of the Merger Agreement. Read SEC document |
| November 28, 2018 Filed Nov 28, 2018 16:18 UTC | AETNA INC /PA/ AET · Entity 107289 | Disposition to issuerPerformance Stock Units · Derivative | 776 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001122304-18-000159 · edgar.xml · derivative · entry 3 Dixon Heather Brianne · CIK 0001720793 · VP, Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 776 shares Expires not disclosed F3 · derivative.exercise_price: Represents Performance Stock Units ("PSUs") earned at a specified level in conjunction with the change in control of Aetna and pursuant to the terms of the relevant PSU award agreement. The PSUs were originally granted under the Plan on September 12, 2016. These PSUs were converted to time-vesting CVS Health Restricted Stock Units ("RSUs") pursuant to the terms of the Merger Agreement. F3 · price: Represents Performance Stock Units ("PSUs") earned at a specified level in conjunction with the change in control of Aetna and pursuant to the terms of the relevant PSU award agreement. The PSUs were originally granted under the Plan on September 12, 2016. These PSUs were converted to time-vesting CVS Health Restricted Stock Units ("RSUs") pursuant to the terms of the Merger Agreement. F3 · derivative.exercise_date: Represents Performance Stock Units ("PSUs") earned at a specified level in conjunction with the change in control of Aetna and pursuant to the terms of the relevant PSU award agreement. The PSUs were originally granted under the Plan on September 12, 2016. These PSUs were converted to time-vesting CVS Health Restricted Stock Units ("RSUs") pursuant to the terms of the Merger Agreement. F3 · derivative.expiration_date: Represents Performance Stock Units ("PSUs") earned at a specified level in conjunction with the change in control of Aetna and pursuant to the terms of the relevant PSU award agreement. The PSUs were originally granted under the Plan on September 12, 2016. These PSUs were converted to time-vesting CVS Health Restricted Stock Units ("RSUs") pursuant to the terms of the Merger Agreement. Read SEC document |
| November 28, 2018 Filed Nov 28, 2018 16:18 UTC | AETNA INC /PA/ AET · Entity 107289 | Disposition to issuerStock Appreciation Rights · Derivative | 2,890 | Not disclosed Strike: $125.27 | Not disclosed |
DisclosureSEC source: 0001122304-18-000159 · edgar.xml · derivative · entry 2 Dixon Heather Brianne · CIK 0001720793 · VP, Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,890 shares Expires not disclosed F2 · price: Represents SARs granted under the Plan on February 17, 2017, of which 33.3% had vested. Each vested SAR was canceled pursuant to the terms of the Merger Agreement in exchange for an amount in cash equal to the SAR Amount. Each unvested SAR was converted to a CVS Health SAR pursuant to the terms of the Merger Agreement. F2 · derivative.exercise_date: Represents SARs granted under the Plan on February 17, 2017, of which 33.3% had vested. Each vested SAR was canceled pursuant to the terms of the Merger Agreement in exchange for an amount in cash equal to the SAR Amount. Each unvested SAR was converted to a CVS Health SAR pursuant to the terms of the Merger Agreement. F2 · derivative.expiration_date: Represents SARs granted under the Plan on February 17, 2017, of which 33.3% had vested. Each vested SAR was canceled pursuant to the terms of the Merger Agreement in exchange for an amount in cash equal to the SAR Amount. Each unvested SAR was converted to a CVS Health SAR pursuant to the terms of the Merger Agreement. Read SEC document |
| November 28, 2018 Filed Nov 28, 2018 16:18 UTC | AETNA INC /PA/ AET · Entity 107289 | Disposition to issuerStock Appreciation Rights · Derivative | 2,706 | Not disclosed Strike: $116.22 | Not disclosed |
DisclosureSEC source: 0001122304-18-000159 · edgar.xml · derivative · entry 1 Dixon Heather Brianne · CIK 0001720793 · VP, Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,706 shares Expires not disclosed F1 · price: Represents Stock Appreciation Rights ("SARs") granted under the Aetna Inc. 2010 Stock Incentive Plan (the "Plan") on September 12, 2016, of which 66.7% had vested. Each vested SAR was canceled pursuant to the terms of the merger agreement (the "Merger Agreement") between CVS Health Corporation ("CVS Health") and Aetna Inc. ("Aetna") in exchange for an amount in cash for each SAR equal to (a) $145 plus (b) 0.8378 multiplied by the average of the volume weighted averages of the trading prices of CVS Health Common Stock on each of the five consecutive trading days ending on the trading day two trading days prior to the closing date, less (c) the exercise price (the "SAR Amount"). Each unvested SAR was converted to a CVS Health SAR pursuant to the terms of the Merger Agreement. F1 · derivative.exercise_date: Represents Stock Appreciation Rights ("SARs") granted under the Aetna Inc. 2010 Stock Incentive Plan (the "Plan") on September 12, 2016, of which 66.7% had vested. Each vested SAR was canceled pursuant to the terms of the merger agreement (the "Merger Agreement") between CVS Health Corporation ("CVS Health") and Aetna Inc. ("Aetna") in exchange for an amount in cash for each SAR equal to (a) $145 plus (b) 0.8378 multiplied by the average of the volume weighted averages of the trading prices of CVS Health Common Stock on each of the five consecutive trading days ending on the trading day two trading days prior to the closing date, less (c) the exercise price (the "SAR Amount"). Each unvested SAR was converted to a CVS Health SAR pursuant to the terms of the Merger Agreement. F1 · derivative.expiration_date: Represents Stock Appreciation Rights ("SARs") granted under the Aetna Inc. 2010 Stock Incentive Plan (the "Plan") on September 12, 2016, of which 66.7% had vested. Each vested SAR was canceled pursuant to the terms of the merger agreement (the "Merger Agreement") between CVS Health Corporation ("CVS Health") and Aetna Inc. ("Aetna") in exchange for an amount in cash for each SAR equal to (a) $145 plus (b) 0.8378 multiplied by the average of the volume weighted averages of the trading prices of CVS Health Common Stock on each of the five consecutive trading days ending on the trading day two trading days prior to the closing date, less (c) the exercise price (the "SAR Amount"). Each unvested SAR was converted to a CVS Health SAR pursuant to the terms of the Merger Agreement. Read SEC document |
| March 02, 2018 Filed Mar 6, 2018 16:18 UTC | AETNA INC /PA/ AET · Entity 107289 | GrantRestricted Stock Units · Derivative | 1,606 | $0.00 | $0.00 |
DisclosureSEC source: 0001122304-18-000036 · edgar.xml · derivative · entry 1 Dixon Heather Brianne · CIK 0001720793 · VP, Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,606 Underlying: Common Stock · 1,606 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a right to receive one share of Aetna Inc. Common Stock net of taxes. F2 · derivative.exercise_date: RSUs granted under the Plan vest in three annual installments beginning December 2, 2018. F2 · derivative.expiration_date: RSUs granted under the Plan vest in three annual installments beginning December 2, 2018. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.